| abstract |
Disclosed is a pharmaceutical composition for treating a patient suffering from asthma, chronic obstructive pulmonary disease (COPD), or other respiratory diseases. An andlast disodium salt that is a calcium-activated potassium channel opener and a group consisting of prednisolone, beclomethasone dipropionate, fluticasone propionate, budesonide, dexamethasone, mometasone furoate, zoticasone, and ciclesonide. A pharmaceutical composition comprising a selected glucocorticoid and a pharmaceutically acceptable carrier or excipient. [Selection figure] None |